TY - JOUR
T1 - Multiplicity and tissue specific expression of camel cytochrome P450(s)
AU - Raza, Haider
AU - John, Annie
AU - Lakhani, Mohammad S.
AU - Ahmed, Ijaz
AU - Montague, William
N1 - Funding Information:
The study was supported by grants from the UAE Terry Fox Cancer Research fund and a grant from the Research Committee, FMHS, UAE University. We also wish to thank Mr K. Assainar and the Media Production Unit for assistance in the preparation of this manuscript.
PY - 1998/11/1
Y1 - 1998/11/1
N2 - The presence of multiple forms of the cytochrome P450 was demonstrated enzymatically in camel tissues using a variety of isoenzyme specific substrates and immunochemically using isoenzyme specific antibodies. The maximum catalytic activity using xenobiotics as substrate was observed in the liver followed by the kidney. However, lauric acid hydroxylation was found to be higher in the kidney than in any other tissues. Camel liver microsomal monooxygenase activity using aniline, aminopyrene, ethoxycoumarin, ethoxyresorufin and benzo(a)pyrene as substrates was comparable with those of rat and human livers. The activity of the enzymes in extrahepatic tissues of the camel was comparable with those of the rat extrahepatic tissues. The maximum expression of P450 protein was seen in the camel liver and kidney while the brain and intestine exhibited relatively low levels of expression. P450 expression in camel tissues appeared to be higher than in rat tissues. Immunohistochemical staining of P450 in the camel liver, kidney and brain confirmed the higher expression of P450 enzyme proteins in the liver and kidney as compared to other extrahepatic tissues. The maximum expression of P450 in the liver was observed in hepatocytes around the central vein and in the kidney it was observed in the proximal tubules. These results demonstrate that the multiple forms of P450s are differentially expressed in camel tissues and that the relative levels of expression are comparable with those of rat and human tissues. These observations may be important in understanding the differential susceptibility of camel tissues to the toxic/therapeutic effects of xenobiotics/drugs and environmental pollution. Copyright (C) 1998 Elsevier Science Inc.
AB - The presence of multiple forms of the cytochrome P450 was demonstrated enzymatically in camel tissues using a variety of isoenzyme specific substrates and immunochemically using isoenzyme specific antibodies. The maximum catalytic activity using xenobiotics as substrate was observed in the liver followed by the kidney. However, lauric acid hydroxylation was found to be higher in the kidney than in any other tissues. Camel liver microsomal monooxygenase activity using aniline, aminopyrene, ethoxycoumarin, ethoxyresorufin and benzo(a)pyrene as substrates was comparable with those of rat and human livers. The activity of the enzymes in extrahepatic tissues of the camel was comparable with those of the rat extrahepatic tissues. The maximum expression of P450 protein was seen in the camel liver and kidney while the brain and intestine exhibited relatively low levels of expression. P450 expression in camel tissues appeared to be higher than in rat tissues. Immunohistochemical staining of P450 in the camel liver, kidney and brain confirmed the higher expression of P450 enzyme proteins in the liver and kidney as compared to other extrahepatic tissues. The maximum expression of P450 in the liver was observed in hepatocytes around the central vein and in the kidney it was observed in the proximal tubules. These results demonstrate that the multiple forms of P450s are differentially expressed in camel tissues and that the relative levels of expression are comparable with those of rat and human tissues. These observations may be important in understanding the differential susceptibility of camel tissues to the toxic/therapeutic effects of xenobiotics/drugs and environmental pollution. Copyright (C) 1998 Elsevier Science Inc.
KW - Camel tissues
KW - Cytochrome P450 isoenzymes
KW - Xenobiotic metabolism
UR - http://www.scopus.com/inward/record.url?scp=0031738747&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031738747&partnerID=8YFLogxK
U2 - 10.1016/S0742-8413(98)10041-5
DO - 10.1016/S0742-8413(98)10041-5
M3 - Article
C2 - 9972462
AN - SCOPUS:0031738747
SN - 0742-8413
VL - 121
SP - 205
EP - 211
JO - Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology
JF - Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology
IS - 1-3
ER -